Covid-19 roundup: Moderna showcases progress on its bivalent booster; Novavax wins approval in Japan
New data from Moderna offer encouraging results for the mRNA powerhouse’s bivalent booster candidate.
The bivalent booster candidate, known as mRNA-1273.211 and which includes mutations …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.